Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288235 · ClinicalTrials.gov registry record · Phase 2
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT01288235: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01288235 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01288235, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
Some patients with brain tumors receive standard radiation to help prevent tumor growth. Although standard radiation kills tumor cells, it can also damage normal tissue in the process and lead to more side effects. This research study is looking at a different form of radiation called proton radiotherapy which helps spare normal tissues while delivering radiation to the tumor or tumor bed. Proton techniques irradiate 2-3 times less normal tissue then standard radiation. This therapy has been used in treatment of other cancers and information from those other research studies suggests that this therapy may help better target brain tumors then standard radiation.
Interventions
- RADIATION Proton radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-02 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01288235
The ClinicalTrials.gov registry entry for NCT01288235 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton radiotherapy is the first listed.
NCT01288235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01288235 about?
NCT01288235 is a clinical study titled "Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation". Some patients with brain tumors receive standard radiation to help prevent tumor growth. Although standard radiation kills tumor cells, it can also damage normal tissue in the process and lead to more side effects. This research study is looking at a different form of radiation called proton radioth...
What is the current status of trial NCT01288235?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2011-02. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01288235?
The interventions under investigation include: Proton radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01288235?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.